LUNG
LUNG
NASDAQ · Health Care

Pulmonx Corp

$1.96
+0.05 (+2.62%)
As of Sep 28, 10:27 PM ET ·
Financial Highlights (FY 2026)
Revenue
95.53M
Net Income
-57,005,234
Gross Margin
74.2%
Profit Margin
-59.7%
Rev Growth
+19.0%
D/E Ratio
0.69
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 74.2% 74.2% 64.5% 64.5%
Operating Margin -59.3% -53.4% 14.2% 15.2%
Profit Margin -59.7% -56.7% 13.0% 12.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 95.53M 80.26M 18.36M 19.89M
Gross Profit 70.87M 59.54M 11.85M 12.83M
Operating Income -56,649,189 -42,833,126 2.61M 3.02M
Net Income -57,005,234 -43,102,336 2.39M 2.44M
Gross Margin 74.2% 74.2% 64.5% 64.5%
Operating Margin -59.3% -53.4% 14.2% 15.2%
Profit Margin -59.7% -56.7% 13.0% 12.3%
Rev Growth +19.0% +19.0% -0.5% +20.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 16.68M 16.68M 22.81M 25.99M
Total Equity 24.33M 24.33M 28.06M 25.55M
D/E Ratio 0.69 0.69 0.81 1.02
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -55,536,404 -44,324,610 3.71M 4.15M
Free Cash Flow — — 1.86M 2.73M